Selective serotonin reuptake inhibitors are the most widely prescribed antidepressants to women during pregnancy. Maternal treatment with fluoxetine can expose fetuses and neonates to higher levels of serotonin that plays a role in stress response. Thus, the aim of the study was to evaluate whether maternal treatment with fluoxetine interferes with aorta reactivity of adult male offspring after acute restraint stress. Wistar rats were gavaged with fluoxetine (5 mg/kg/day) or water (control) during pregnancy and lactation. The experiments were performed in adult male offspring, treated or not with reserpine (4 mg/Kg, ip, 28 h before the experimental protocol). Fluoxetine and control rats were submitted to a single restraint stress session (ST) for 1 h. Curves to phenylephrine were performed in thoracic aorta with endothelium. Aortic nitric oxide (NOx) were evaluated by the Griess method. The aortic contraction induced by phenylephrine was similar between control and fluoxetine rats. The acute stress reduced contraction in aorta of control ST compared to control, and L-NAME equaled this response. In fluoxetine rats, ST did not change the aortic constriction. Reserpine treatment restored the vasoconstriction in control ST, but did not interfere with aortic contraction in control, fluoxetine or fluoxetine ST. The NOx concentration was higher in aortas from control ST than control rats, and reserpine reduced NOx levels of control ST. The NOx concentration was similar between fluoxetine and fluoxetine ST rats, treated or not with reserpine. In conclusion, maternal treatment with fluoxetine blunted acute restraint stress-induced NO system activation and aortic adaptation in adult offspring.
Introduction
According to the "Developmental Origins of Health and Disease" (DOHaD) theory, events such as illness or exposure to xenobiotics that occur during intrauterine and neonatal development can later influence the individual's health in adulthood (Gluckman et al., 2009; Sinclair et al., 2007) . Women are likely to use antidepressants during pregnancy and/or breastfeeding for two different reasons: if they are already using the drug before becoming pregnant and the treatment cannot be discontinued under the risk of relapse or recurrence of the disease or if they fall ill during pregnancy or breastfeeding and need to start using medication (Andrade et al., 2008) .
Nowadays, selective serotonin reuptake inhibitors (SSRIs) are the most widely prescribed antidepressants to pregnant women due to their efficacy associated with few side effects (Barbey and Roose, 1998; Gentile, 2005 ) even though they have been associated with an increased risk of pregnancy complications such as preterm birth (Wisner et al., 2009) .
Fluoxetine is one of the most commonly used SSRIs to treat depression and anxiety disorders (Zohar and Westenberg, 2000) , and in the management of neuropathic pain (McQuay et al., 1996) and it has been used during pregnancy and lactation. This drug acts by inhibiting the serotonin reuptake and increasing its concentration in the synaptic cleft. The pharmacokinetics of fluoxetine have already been widely described as has its ability to cross the human placenta (Heikkinen et al., 2002) and be excreted in the breast milk recognized (Hendrick et al., 2001) , exposing the fetus and neonate to supraphysiological serotonin levels (Bonnin and Levitt, 2011) .
Since its discovery, serotonin has been reported to play a role in stress response (Chaouloff et al., 2015) . In fact, offspring exposure to fluoxetine during pregnancy and lactation presents decreased corticosterone plasmatic level (Pawluski et al., 2012) and lower activation of the basolateral amygdala in response to an acute restraint stress (Francis-Oliveira et al., 2013) , indicating that modifications in the serotonergic system homeostasis during early development can influence both basal and stress-induced activity of the hypothalamus-pituitary-adrenal axis.
Acute restraint stress induces hypo-reactivity to alpha-1 adrenergic agonists in the aorta of rats by mechanisms involving nitric oxide (NO) and sympathetic systems activation (Cordellini and Vassilieff, 1998) . However, as far as we know, the consequences of intrauterine and lactation exposure to fluoxetine on vascular response induced by acute restraint stress have not been evaluated. Thus, the present study aimed to evaluate whether maternal treatment with fluoxetine during gestation and lactation can interfere with aorta reactivity after acute restraint stress in rats. The role of NO and sympathetic nervous systems were also evaluated.
Materials and methods

Animals
Male and female naive Wistar rats were mated (three females and one male per cage) overnight. Gestational day 0 (GD0) was diagnosed if there were spermatozoa and oestrus-phase cells in vaginal smears. Dams were housed singly and randomly divided into the control (n = 18) or fluoxetine (n = 12) group. Control dams were gavaged daily with tap water whereas the fluoxetine dams were gavaged with Fluoxetine (5 mg/kg, Daforin® oral solution EMS Laboratory, Brazil) diluted in tap water. The fluoxetine dose of 5 mg/kg/day was chosen based on previous studies from our group and also considering the absence of toxicity for dams and litters (Francis-Oliveira et al., 2013; Higashi et al., 2016) . Dam weights were obtained every three days throughout pregnancy and lactation for dose adjusting. The birth day was denominated post-natal day (PND) 0, and at PND 4 the litter was reduced to ten pups (sex balanced) to avoid bias related to availability of fluoxetine via lactation. Considering that, a previous study from our group demonstrated that male offspring exposed to FLX presented behavioral alteration after acute restraint stress (Francis-Oliveira et al., 2013) in the present study just the male progeny was applied. At PND 21, male pups were weaned and housed in five male animals per cage. For the present study 30 fluoxetine and 50 control male offspring were used. All animals had free access to water and regular chow (Nuvital, Curitiba, Brazil) . The rats were maintained at 21 ± 2°C on a 12:12 h light-dark cycle (lights on at 06:00 a.m.). Different littermates (one male) from each litter were used for each evaluation conducted. All experimental protocols were approved by the State University of Londrina Ethics Committee for Animal Research (CEUA no.16166.2012.12).
Stress induction
At PND 75-80, male rats from both groups were submitted to 1 h restraint stress, which consisted of immobilization in metal conical tubes with holes to allow ventilation (Francis-Oliveira et al., 2013) . To evaluate the role of the sympathetic system in the vascular response, 24 h before the stress induction, a single dose of reserpine (Res) (Merck®, 4 mg/kg, i.p.), a catecholamine depleting drug (NavarroOliveira et al., 2000) , was administrated to rats from all groups.
Aorta reactivity
Immediately after stress exposure, the thoracic aorta was removed from anesthetized rats (sodium thiopental 40 mg/kg, i.p. -Cristália, Brazil). Segments of the thoracic aorta (4 mm in length), free of connective tissue, with (Endo+) or without (Endo-) endothelium, were mounted in a tissue chamber with Krebs-Henseleit solution (containing in mM: 118 NaCl, 4.7 KCl, 25 NaHCO3, 2.5 CaCl2⋅ 2H2O, 1.2 KH2PO4, 1.2 MgSO4⋅ 7H2O, 11 glucose, and 0.01 EDTA), gassed with 95% O2-5% CO2, and maintained at a resting tension of 1.5 g at 37°C at pH 7.4, as previously published by our group (Higashi et al., 2016) . To test the catecholamine depletion, in rats treated with reserpine, tyramine (100 µM, Calbiochem®) was added to the aortic rings bath. Next, to test the smooth muscle viability, the aortic rings were stimulated with KCl (90 mM). To evaluate the endothelium integrity, the aortic rings were contracted with phenylephrine and acetylcholine (0.1 mM), an endothelium-dependent vasodilator. Endothelium was considered preserved if acetylcholine promoted 70-80% relaxation and removed if acetylcholine promoted less than 5% relaxation. Cumulative concentration-effect curves to phenylephrine (1 nM to 30 μM), acetylcholine (1 nM to 30 μM), or sodium nitroprusside (1 nM to 30 μM) were performed in aortic rings. The aortic response to phenylephrine was also evaluated in the presence of N-nitro-L-arginine methyl ester (L-NAME − 1 µM), a NO synthase (NOS) inhibitor. The maximal response (MaxR) to phenylephrine was expressed in grams of tension (g) and the MaxR to the vasodilators was expressed as a percentage of phenylephrine-induced contraction. The log of drug concentration resulting in 50% of the MaxR (pD2) was calculated using non-linear regression analysis (GraphPad Prism software, USA).
NO levels in aortic tissue
Aortic tissue was obtained from anesthetized rats (sodium thiopental 40 mg/kg, i.p. -Cristália, Brazil). The NO levels were assessed on the basis of nitrite and nitrate concentration according to the Griess reaction, supplemented by the reduction of nitrate to nitrite with cadmium (Navarro-Gonzálvez et al., 1998). The aortas were subjected to homogenization in phosphate-buffered saline to the final concentration of 100 mg of wet weight tissue/mL of saline (Panis et al., 2011) . The results are reported as percentage of NO metabolites (NOx) in the control group.
Statistical analysis
Initially, an exploratory analysis was conducted to evaluate normality of each variable and homogeneity of variance among the groups. Since criteria for normality and homogeneity of variances were reached (P > 0.05), the variables were evaluated by one-way ANOVA (MaxR and pD2 to vasodilators and to phenylephrine in Endo-aortic rings) or three-way (MaxR and pD2 to phenylephrine in the Endo+ aortic rings and NOx aortic levels). For three-way ANOVA, the factors were: exposure (control or fluoxetine), inhibitors (H2O, reserpine or L-NAME), and stress. If three-way ANOVA indicated significant interaction between factors, all data were analyzed together by one-way ANOVA complemented with Bonferroni's test. Conclusions were established at P ≤ 0.05 and only biologically important differences described. The results are shown as mean ± standard error of the mean (S.E.M.).
Results
Fluoxetine early exposure blunted the aortic hypo-contraction after stress
Phenylephrine induced concentration-dependent contraction in Endo+ (Figs. 1 and 2) and Endo- (Fig. 3) aortic rings isolated from all groups.
Three-way ANOVA indicated an interaction between the factors exposure and stress [F(1, 94) = 3.50, P = 0.05] and stress and reserpine [F(1, 39) = 5.22; P = 0.025]. One way ANOVA indicated that MaxR to phenylephrine was different between the control, fluoxetine, control ST, and fluoxetine ST rats [F(3, 52) = 7.59, P = 0.0003]. Bonferroni's test showed a decrease in MaxR to phenylephrine in Endo + aortic rings isolated from control ST rats when compared with Endo + aortic rings from control rats (Table 1, Fig. 1A) . Also, in fluoxetine rats, acute stress did not change the MaxR to phenylephrine in Endo+ aortic rings (Table 1, Fig. 1B) . One-way ANOVA also indicated that reserpine treatment changed the aortic contraction after stress [F(3, 36) = 3.64, P = 0.03] and Bonferroni's test showed that in control ST rats reserpine treatment restored the MaxR to the vasoconstrictor on Endo+ aortic rings, abolishing the hypo-contraction induced by acute stress (Table 1, Fig. 1A ). In control, fluoxetine, and fluoxetine ST rats treatment with reserpine did not affect the MaxR to phenylephrine in Endo + aortic rings, in comparison with rings from untreated rats (Table 1 , Fig. 1A and B) . The pD2 to phenylephrine was similar between aortic rings Endo+ from different groups (Table 1) .
Three-way ANOVA indicated an interaction between the factors exposure and stress [F(1, 43) = 6.28, P = 0.02] and, L-NAME and stress [F(1, 89) = 3.89, P = 0.05]. One-way ANOVA and Bonferroni's test demonstrated that the NOS inhibitor, L-NAME, increased the MaxR to phenylephrine of Endo+ isolated from control and control ST rats (Table 1, Fig. 2A ), abolishing the aortic hypo-reactivity induced by stress. In addition, L-NAME increased the contraction induced by phenylephrine in Endo+ rings isolated from fluoxetine and fluoxetine ST rats (Table 1, Fig. 2B ). The pD2 for phenylephrine was similar between the groups (Table 1) .
One way ANOVA indicated that endothelium removal (Fig. 3 ) equaled the MaxR to phenylephrine in aortic rings from control (3.40 ± 0.24, n = 15), fluoxetine (3.59 ± 0.25, n = 10), control ST (3.34 ± 0.16, n = 12), and fluoxetine ST rats (3.71 ± 0.43, n = 5) [F (3, 38) = 0.13, P = 0.94]. The pD2 to phenylephrine was similar between aortic rings Endo-from different groups (data not shown).
Acetylcholine and sodium nitroprusside caused concentrationdependent relaxation in aortic rings. As demonstrated in Table 2, Bonferroni's test. Fig. 3 . Aortic response to phenylephrine in the absence of endothelium. Concentration-effect curves to phenylephrine (Phe -1 nmol/L to 30 µmol/L) in aortic rings without endothelium isolated from control, fluoxetine exposed male offspring, submitted or not to acute restraint stress (ST). Each point represents the mean ± S.E.M.
(n) is the number of rats/group, P > 0.05, three-way ANOVA.
NOx aortic tissue levels
Three-way ANOVA indicated an effect of stress [F(1.21) = 7.31, P = 0.01] and reserpine [F(1, 11) = 3.83, P = 0.05] for NOx concentration in the aorta. One way ANOVA [F(5, 43) = 5.06, P = 0.001] and Bonferroni's test revealed that NOx was increased in the aortas isolated from control ST when compared with control rats and the treatment with reserpine reduced NOx levels in the control ST aortas. The NOx aortic concentration was similar in fluoxetine and fluoxetine ST rats, treated or not with reserpine (Fig. 4) .
Discussion
The present study demonstrated that maternal treatment with fluoxetine during gestation and lactation inhibited the aortic hypocontraction induced by acute restraint stress in adult male offspring.
As previously described (Jansakul, 1995; Junior and Cordellini, 2007; Meerson et al., 1991; Navarro-Oliveira et al., 2000) , aortic hyporeactivity induced by acute restraint stress depends on the presence of endothelium and is related to NO, since the blockade of NOS isoforms reverts this response (Cordellini and Vassilieff, 1998; Jansakul, 1995) . Indeed, the present study confirms that acute restraint stress increases aortic NO and that L-NAME, a nonselective NOS inhibitor, as well as removing endothelium, restores the aorta contractile response in control ST rats. It should be noted, however, that Carda et al. (2015) reported an increased aorta contractive response to phenylephrine after an acute stress accompanied by reduced NO levels and suggested that cyclooxygenase-derived prostanoids and oxidative stress were involved in these effects. The apparent discrepancy between the results from Carda and our results may be explained by the experimental design, since their stress protocol lasted 2 h, while our protocol lasted 1 h, and the evaluation was conducted 24 h after the stress session, while ours took place immediately after the session. It has also been described that rat behavior 24 h after the stressor stimulus is different from that observed 1 h after the stressor stimulus (Padovan and Guimarães, 2000) , suggesting that the protocol used to evaluate the effects of acute restraint stress can influence behavioral and, in our case, vascular response.
Stress is one of the factors that activate the sympathetic nervous system as well as the hypothalamic-pituitary-adrenocortical axis (Pacak et al., 1995; Sabban and Kvetňansk, 2001) . SSRI antidepressants are effective in reducing stress-induced sympathetic nervous system activation in psychiatrically healthy people (Golding et al., 2005) and psychiatric patients (Straneva-Meuse et al., 2004 ) decreasing cardiovascular response (Golding et al., 2005; Straneva-Meuse et al., 2004; Tucker et al., 2000) . Also in rodent models treatment with SSRI prevents endothelial dysfunction induced by chronic stress (Isingrini et al., 2012) . However, the consequences of maternal treatment with SSRI upon vascular response to acute stress in exposed offspring are not completely understood.
The acute restraint stress-induced aortic hypo-contraction has been related to a sympathetic activation, leading to increased NO system activity (Navarro-Oliveira et al., 2000) . In fact, our results show that adrenergic inhibition with reserpine blunted the aortic hypo-contraction and increased NO in the aortas of control ST rats. On the other hand, in fluoxetine exposed rats reserpine did not interfere with the vascular contraction or with NO levels after acute stress, suggesting a lower activation of the adrenergic system in these rats. This hypothesis is supported by a previous study from our group which employed the same fluoxetine exposure and stress protocols and reported reduced activation of the basolateral amygdala and paraventricular nucleus to Table 1 Phenylephrine-induced contraction in aortic rings isolated from male rats exposed and not exposed (control) to fluoxetine during development, after acute restraint stress (ST), treatment with reserpine (Res) and aortic incubation with L-NAME. The maximal response is expressed in grams (g) of tension and pD2 is the negative log of the agonist concentration resulting in 50% of the maximal response. The phenylephrine-induced contraction was evaluated in endothelium-intact aortic rings. The values are expressed as mean ± S.E.M. (n) is the number of rats/group.
Groups
Maximal response (g) pD2
Control (18) 2.69 ± 0.12 6.52 ± 0.15 Fluoxetine (12) 2.56 ± 0.19 6.48 ± 0.20 Control ST (16) 1.93 ± 0.11 a 6.58 ± 0.12 Fluoxetine ST (5) 2.51 ± 0.25 6.32 ± 0.40 Control Res (7) 2.59 ± 0.14 6.45 ± 0.19 Fluoxetine Res (5) 2.33 ± 0.30 6.50 ± 0.29 Control ST Res (9) 2.45 ± 0.20 b 5.98 ± 0.23 Fluoxetine ST Res (8) 2.19 ± 0.20 5.76 ± 0.22 Control L-Name (8) 3.75 ± 0.16 a 7.13 ± 0.12 Fluoxetine L-Name (5) 3.08 ± 0.22 Table 2 Acetylcholine and sodium nitroprusside (SNP)-induced relaxation in aortic rings isolated from male offspring exposed to fluoxetine or not (control) during development after acute restraint stress (ST). The maximal responses (MaxR) to acetylcholine (ACh) and sodium nitroprusside (SNP) are expressed as the percentage of phenylephrine-induced contraction and pD2 is the negative log of the agonist concentration resulting in 50% of the maximal response. The values are expressed as mean ± S.E.M. (n) is the number of rats/group, one-way ANOVA and Bonferroni's test, P > 0.05. B.V.D. Marques et al. European Journal of Pharmacology 813 (2017) 147-152 stress in the fluoxetine exposed rats (Francis-Oliveira et al., 2013) , which are important areas related to sympathoexcitatory responses. Altogether, it is possible to suggest that fluoxetine developmental exposure could have a long term effect on the progeny's sympathetic activation, influencing the vascular adaptive response to a stressor challenge. The blunted aortic hypo-contractive response to acute restraint stress in fluoxetine exposed male offspring could be related to a possible endothelial dysfunction or reduction in the vascular smooth muscle sensitivity to NO. However, the endothelium-dependent relaxation induced by acetylcholine, as well as the vasoconstriction induced by phenylephrine in the presence of endothelium and response to sodium nitroprusside were preserved in the aortas isolated from fluoxetine exposed male offspring. As far as we know, the vascular implications of fluoxetine exposure in utero are limited. The information available describes that fluoxetine exposure in utero caused pulmonary vascular hypertrophy in rats (Fornaro et al., 2007; Porzionato et al., 2012) , impaired aortic contraction in female rats (Higashi et al., 2016) , and elevated (Emory and Dieter, 2006) or decreased fetal middle cerebral artery blood flow in humans (Rurak et al., 2011) . In this way, we suggest that the absence of aortic hypo-contraction after acute restraint stress was not related with endothelial dysfunction and a possible reduction in basal NO bioavailability; it probably resulted from poor NO system activation by the acute restraint stress.
In conclusion, if the aortic hypo-contraction induced by acute restraint stress is a natural adaptive response required to face abnormal situations, our results suggest that maternal fluoxetine treatment disturbs this vascular adaptation, since aortas from fluoxetine rats did not present the expected hypo-contraction induced by acute restraint stress. This lack of adaptation seems to have resulted from reduced activation of the NO system, caused by alterations in central nervous system development (Francis-Oliveira et al., 2013 ) that might impair the sympathetic autonomic activation.
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